There was deserved recognition for Dr Ruth McKernan CBE, founder of the biotech AstronauTx, at one of the most prominent events in the life science calendar. Dr McKernan won the Most Significant Contribution to the Mediscience Sector Award at the European Mediscience Awards on Thursday evening. Optimum Strategic Communications proudly worked with AstronauTx to announce […]
This week showcased the diverse projects and research that Optimum’s clients are involved with. These included STORM Therapeutics’ groundbreaking research into METTL3, an exciting new target in cancer therapy that was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, the biggest oncology meeting in the world. In the same week, our client […]
After a rainy bank holiday weekend, the four-day week was jam-packed with action for the Optimum team, as our client Calliditas recommended shareholders accept a $1 billion+ takeover offer. Calliditas receives public offer by Asahi Kasei Corporation Asahi Kasei Corporation announced on Tuesday a public cash offer to acquire all shares and American Depositary Receipts […]
The great and the good of biotech descended on San Sebastian, Spain, for the influential Bio€quity Europe conference, one of the major dealmaking and networking events of the year. Despite inclement weather, the conference was sold out, allowing CEOs and investors to gather, network, partner and debate issues facing the biotech industry. Representatives of the […]
From a major international investment event, to a new way to use the complement system to fight cancer, here’s what Optimum and its clients have been doing this week. Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation join forces to accelerate global health equity and Novo Nordisk Foundation gives grants for global […]
